Findings seen in analysis of e-cigarettes and e-cigarette liquids from 11 flavors of two products
TUESDAY, Aug. 13, 2024 (HealthDay News) — There are discrepancies between labeled and measured concentrations of nicotine analogues in electronic cigarettes and e-cigarette liquids, according to a research letter published online Aug. 7 in the Journal of the American Medical Association.
Hanno C. Erythropel, Ph.D., from Yale University in New Haven, Connecticut, and colleagues quantified constituents of e-cigarette products containing nicotine analogues to assess product consistency. The analysis included nine available flavors of product 1 labeled as containing 5 percent 6-methylnicotine (6MN) and two flavors of product 2 at four concentrations of nicotinamide (0, 12, 24, and 36 mg/mL) that were purchased between November 2023 and February 2024 from three major online retailers.
The researchers found that 6MN presence was confirmed in all product 1 flavors. Both nicotinamide and 6MN were detected in product 2 samples labeled as containing nicotinamide (six of eight). No sample contained nicotine. Product 1 was labeled as containing 5 percent 6MN (50 mg/g), but the analysis showed it only contained 5.8 to 6.3 mg/g (87 to 88 percent less than labeled). In product 2, samples contained nicotinamide contents 7 to 46 percent less than as labeled. Although product 2 labels did not list 6MN as an ingredient, 6MN was detected (0.06 to 0.17 mg/g) when nicotinamide was present. Product 1 samples contained only the (S)-6MN stereoisomer, which previous research showed is more potent and addictive than the (R) form. Product 1 samples all contained the artificial sweetener neotame (0.20 to 0.86 mg/g) and the synthetic coolant 2-isopropyl-N-2,3-trimethylbutyramide (WS-23; 4.34 to 16.39 mg/g) plus various flavorants, whereas product 2 samples did not contain sweeteners or coolants.
“With e-cigarettes increasingly considered for smoking cessation, the advent of nicotine analogue-containing products with unknown health risks raises concern,” the authors write.
Abstract/Full Text (subscription or payment may be required)
2009 to 2023 Saw Surge in Probiotic Supplement Use
Updated Guideline Developed for Diagnosis, Management of Childhood Nocturnal Enuresis
Nearly 2 in 3 Poison Exposures in Young Children May Not Need the ED
Longer Reproductive Lifespan Tied to Lower Bronchiectasis Risk in Postmenopausal Women
Midlife Onset of Increasing Pulse Pressure Not Linked to Menopause
Estrogen Hormone Treatment May Be Beneficial for Brain Fog Symptoms in Menopausal Women
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children
Fractional Exhaled Nitric Oxide Elevated in Pediatric Chest Tightness Variant Asthma